Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 Jan;7(1 Suppl 1):s15-6.

Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report

Darrell S Rigel  1 , Abel M Torres, Haines Ely
Affiliations
  • PMID: 18277458
Clinical Trial

Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report

Darrell S Rigel et al. J Drugs Dermatol. 2008 Jan.

Abstract

Background: Using more than one therapeutic approach in the treatment of basal cell carcinomas (BCCs) has the potential to enhance cure rates.

Materials and methods: In this study, 57 nodular and superficial BCCs were curetted without electrodesiccation. One week later, imiquimod 5% cream therapy was initiated once daily 5 times per week for 6 weeks. At 1-year follow-up, 0 of 57 BCCs (0%) had clinical recurrences. Cosmetic results were very good to excellent.

Conclusion: Combination therapy with imiquimod 5% cream followed by curettage represents an effective method for treating BCCs with a high cure rate.

PubMed Disclaimer